Bone morphogenetic proteins (BMPs) have been widely used for bone repair in the craniofacial region. However, its high dose requirement in clinical applications revealed adverse effects and inefficient bone formation, along with high cost. Here, we report a novel osteoinductive strategy to effectively complement the osteogenic activity of BMP-2 using phenamil, a small molecule that can induce osteogenic differentiation via stimulation of BMP signaling. Treatment of adipose-derived stem cells (ASCs) with BMP-2 in combination with phenamil significantly promoted the in vitro osteogenic differentiation of ASCs. The efficacy of the combination strategy of phenamil+BMP-2 was further confirmed in a mouse calvarial defect model using scaffolds consisting of poly(lactic-co-glycolic acid) and apatite layer on their surfaces designed to slowly release phenamil and BMP-2. Six weeks after implantation, the scaffolds treated with phenamil+BMP-2 significantly promoted mouse calvarial regeneration as demonstrated by micro-computerized tomography and histology, compared with the groups treated with phenamil or BMP-2 alone. Moreover, the combination treatment reduced the BMP-2 dose without compromising calvarial healing efficacy. These results suggest promising complementary therapeutic strategies for bone repair in more efficient and cost-effective manners.
Get full access to this article
View all access options for this article.
References
1.
KneserU., SchaeferD.J., PolykandriotisE., and HorchR.E.Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med, 10, 7, 2006.
2.
TatumS.A., and KellmanR.M.Cranial bone grafting in maxillofacial trauma and reconstruction. Facial Plast Surg, 14, 117, 1998.
3.
BaqainZ.H., AnabtawiM., KarakyA.A., and MalkawiZ.Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: an outcome assessment study. J Oral Maxillofac Surg, 67, 570, 2009.
4.
GlassmanS.D., CarreonL.Y., DjurasovicM., CampbellM.J., PunoR.M., JohnsonJ.R., and DimarJ.R.RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976), 33, 2843, 2008.
5.
CahillK.S., ChiJ.H., DayA., and ClausE.B.Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA, 302, 58, 2009.
6.
AghalooT., JiangX., SooC., ZhangZ., ZhangX., HuJ., PanH., HsuT., WuB., TingK., and ZhangX.A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther, 15, 1872, 2007.
7.
ChenN.F., SmithZ.A., StinerE., ArminS., SheikhH., and KhooL.T.Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine, 12, 40, 2010.
8.
PerriB., CooperM., LauryssenC., and AnandN.Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J, 7, 235, 2007.
9.
LaurencinC.T., AsheK.M., HenryN., KanH.M., and LoK.W.Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications. Drug Discov Today, 19, 794, 2014.
10.
MundyG., GarrettR., HarrisS., ChanJ., ChenD., RossiniG., BoyceB., ZhaoM., and GutierrezG.Stimulation of bone formation in vitro and in rodents by statins. Science, 286, 1946, 1999.
11.
ZhouY., NiY., LiuY., ZengB., XuY., and GeW.The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials, 31, 5325, 2010.
12.
DaiW., DongJ., FangT., and UemuraT.Stimulation of osteogenic activity in mesenchymal stem cells by FK506. J Biomed Mater Res A, 86, 235, 2008.
13.
IsomotoS., HattoriK., OhgushiH., NakajimaH., TanakaY., and TakakuraY.Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci, 12, 83, 2007.
14.
ParkK.W., WakiH., KimW.K., DaviesB.S., YoungS.G., ParhamiF., and TontonozP.The small molecule phenamil induces osteoblast differentiation and mineralization. Mol Cell Biol, 29, 3905, 2009.
15.
ChanM.C., NguyenP.H., DavisB.N., OhokaN., HayashiH., DuK., LagnaG., and HataA.A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Mol Cell Biol, 27, 5776, 2007.
16.
JamesA., ChungC.G., AsatrianG., VelascoO., HalperinD., ParkK.W., BayaniG., KhadarianK., ZhangX., TingK., TontonozP., and SooC.The Oral Small Molecule Phenamil Regulates BMP Signaling and Prevents Ovariectomy-Induced Osteoporosis. Abstract presented at the ASBMR Annual Meeting, Baltimore, MD, 2013. Abstract no. 1086.
17.
LoK.W., UleryB.D., KanH.M., AsheK.M., and LaurencinC.T.Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering. J Tissue Eng Regen Med, 8, 728, 2014.
18.
KimJ.G., SonK.M., ParkH.C., ZhuT., KwonJ.H., and YangH.C.Stimulating effects of quercetin and phenamil on differentiation of human dental pulp cells. Eur J Oral Sci, 121, 559, 2013.
19.
LoK.W., KanH.M., and LaurencinC.T. Short-term administration of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells. J Tissue Eng Regen Med, 2013 [Epub ahead of print]; DOI: 10.1002/term.1786.
20.
ChouY.F., DunnJ.C., and WuB.M.In vitro response of MC3T3-E1 pre-osteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B Appl Biomater, 75, 81, 2005.
21.
HuJ., HouY., ParkH., and LeeM.Beta-tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering. J Biomed Mater Res A, 100, 1680, 2012.
22.
ParkH., ChoiB., NguyenJ., FanJ., ShafiS., KlokkevoldP., and LeeM.Anionic carbohydrate-containing chitosan scaffolds for bone regeneration. Carbohydr Polym, 97, 587, 2013.
23.
FanJ., ParkH., TanS., and LeeM.Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2. PLoS One, 8, e72474, 2013.
24.
FanJ., ParkH., LeeM.K., BezouglaiaO., FartashA., KimJ., AghalooT., and LeeM.Adipose-Derived Stem Cells and BMP-2 Delivery in Chitosan-Based 3D Constructs to Enhance Bone Regeneration in a Rat Mandibular Defect Model. Tissue Eng Part A, 20, 2169, 2014.
AghalooT., CowanC.M., ChouY.F., ZhangX., LeeH., MiaoS., HongN., KurodaS., WuB., TingK., and SooC.Nell-1-induced bone regeneration in calvarial defects. Am J Pathol, 169, 903, 2006.
27.
EpsteinN.E.Pros, cons, and costs of INFUSE in spinal surgery. Surg Neurol Int, 2, 10, 2011.
28.
Valentin-OpranA., WozneyJ., CsimmaC., LillyL., and RiedelG.E.Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res, 395, 110, 2002.
29.
GimbleJ.M., KatzA.J., and BunnellB.A.Adipose-derived stem cells for regenerative medicine. Circ Res, 100, 1249, 2007.
PascaudP., ErrassifiF., BrouilletF., SardaS., BarrougA., LegrouriA., and ReyC.Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules. J Mater Sci Mater Med, 25, 2373, 2014.
34.
ChouJ., ItoT., BishopD., OtsukaM., Ben-NissanB., and MilthorpeB.Controlled release of simvastatin from biomimetic β-TCP drug delivery system. PLoS One, 8, e54676, 2013.
35.
UskokovićV., and UskokovićD.P.Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res B Appl Biomater, 96, 152, 2011.
36.
BarrereF., van BlitterswijkC.A., de GrootK., and LayrolleP.Influence of ionic strength and carbonate on the Ca-P coating formation from SBFx5 solution. Biomaterials, 23, 1921, 2002.
37.
DongX., WangQ., WuT., and PanH.Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J, 93, 750, 2007.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
